Assignee
MIRUM PHARMACEUTICALS INC
US·5 granted patents·13 pending applications·9 citations·filing 2020–2025
Top patents by PatentIndex Score
18 records- 0191US11918578B2Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·2 cites·17 claims
- 0291US11497745B2Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2021·Granted Nov 15, 2022·3 cites·13 claims
- 0391US11229647B2Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2020·Granted Jan 25, 2022·4 cites·13 claims
- 0486US2025360127A1Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0585US2024189308A1Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0673US12576079B2Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2020·Granted Mar 17, 2026·0 cites·15 claims
- 0768US2022133738A1Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiencyMIRUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0868US2022152022A1Methods for increasing growth in pediatric subjects having cholestatic liver diseaseMIRUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0968US2022160726A1Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1063US12296050B2Pharmaceutical compositions comprising maralixibat and uses thereofMIRUM PHARMACEUTICALS INC·Filed 2023·Granted May 13, 2025·0 cites·28 claims
- 1160US2023190743A1Treatment with ileal bile acid transporter (ibat) inhibitors for increased event-free survival (efs)MIRUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1259US2023138455A1METHODS OF DOSING OF APICAL SODIUM-DEPENDENT BILE ACID TRANSPORTER INHIBITORS (ASBTIs)MIRUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1358US2024173317A1Methods for treating progressive familial intrahepatic cholestasisMIRUM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1456US2024116891A1Maralixibat solid forms, intermediates and processes of making sameMIRUM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1554US2023181527A1Apical sodium-dependent transporter inhibitor compositionsMIRUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1652US2024382507A1Pharmaceutical compositions comprising 2,3,4,5- tetrahydrobenzothiepin- 1,1-dioxide derivatives and the use thereofMIRUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1750US2026090993A1Pharmaceutical compositions comprising maralixibat and uses thereofMIRUM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1841US2025345326A1Methods for treating cholestatic pruritusMIRUM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MIRUM PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →